Application of a Systems Pharmacology‐Based Placebo Population Model to Analyze Long‐Term Data of Postmenopausal Osteoporosis

Publisher： John Wiley & Sons Inc

E-ISSN： 2163-8306|2163-8306|9|516-526

ISSN： 2163-8306

Source： Cpt: Pharmacometrics & Systems Pharmacology, Vol.2163-8306, Iss.9, 2015-09, pp. : 516-526

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Application of a Systems Pharmacology‐Based Placebo Population Model to Analyze Long‐Term Data of Postmenopausal Osteoporosis

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 9, 2015-09 ,pp. : 516-526

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of long-term bisphosphonates in postmenopausal osteoporosis

By Miller Paul D  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2253-2258

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Tolerability of the Bisphosphonates in Postmenopausal Osteoporosis: A Comparative Review

By Kherani R.B.   Papaioannou A.   Adachi J.D.  

Drug Safety, Vol. 25, Iss. 11, 2002-01 ,pp. : 781-790

Adis International

Access to resources Recommend Favorite

Safety concerns with the long-term management of osteoporosis

By Reginster Jean-Yves  

Expert Opinion on Drug Safety, Vol. 12, Iss. 4, 2013-07 ,pp. : 507-522

Informa Healthcare

Access to resources Recommend Favorite

Safety of Long-Term Bisphosphonate Therapy for the Management of Osteoporosis

By Lewiecki E. Michael  

Drugs, Vol. 71, Iss. 6, 2011-04 ,pp. : 791-814

Adis International

Access to resources Recommend Favorite